MAPT and Alzheimer disease: Transplantation of bone marrow-derived MSCs improves cognitive deficits by reducing Aβ protein and tau aggregates, decreasing intercellular tau hyperphosphorylated aggregates and tau tangles, mitigating apoptosis due to aberrant protein clearance, and inhibiting neuroinflammation in AD [65].